HCPCS Level IIdrugActive
J9056
Inj, vivimusta, 1 mg
BETOS: O1E
Effective: 2025-01-01
Description
Injection, bendamustine hydrochloride (vivimusta), 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Vivimusta
Manufacturer
Azurity Pharmaceuticals, Inc.
HCPCS Dosage
1 MG
Billing Units
100.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.